JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: TCS-PIM-1-4a ( (the mixture of E- and Z-enantiomers of SMI-4a) is a novel Pim inhibitor with IC50 of 13 nM for Pim-1 and 2.3 uM for Pim-2. The Pim protein kinases are frequently overexpressed in prostate cancer and certain forms of leukemia and lymphoma. TCS-PIM-1-4a was identified by screening to be a Pim-1 inhibitor and was found to attenuate the autophosphorylation of tagged Pim-1 in intact cells. Although TCS-PIM-1-4a is a competitive inhibitor with respect to ATP, a screen of approximately 50 diverse protein kinases demonstrated that it has high selectivity for Pim kinases. Overall, TCS-PIM-1-4a represents a new Pim kinase inhibitor that may provide leads to novel anticancer agents.
References: Proc Natl Acad Sci U S A. 2011 Jan 11; 108(2):528-33.; Mol Cancer Ther. 2009 Jun; 8(6):1473-83; Blood. 2010 Jan 28; 115(4):824-33.
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Delivery expected until 9/6/2024
Compare
Add to wishlist
Recommend by mail
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!